ACCL vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 02, 2026

ACCL

51.2
AI Score
VS
MLAB Wins

MLAB

51.5
AI Score

Investment Advisor Scores

ACCL

51score
Recommendation
HOLD

MLAB

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACCL MLAB Winner
Revenue 4.85M 249.13M MLAB
Net Income 1.02M 6.71M MLAB
Gross Margin 44.1% 63.5% MLAB
Net Margin 21.1% 2.7% ACCL
Operating Income 1.08M 18.51M MLAB
ROE 46.7% 3.6% ACCL
ROA 26.1% 1.6% ACCL
Total Assets 3.91M 427.75M MLAB
Cash 2.45M 26.93M MLAB
Current Ratio 1.82 1.72 ACCL
Free Cash Flow 1.51M 39.58M MLAB

Relative Price Performance (Last 90 Days)

ACCL 1M: +32.7% · 3M: +48.7% MLAB 1M: -3.4% · 3M: +0.8%

Current Technical Phase

ACCL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (13.8% over 20 days), RSI 76

RSI (14): 75.8 · Price: $2.23

MLAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.5 · Price: $100.81

Fundamentals Snapshot

Metric ACCL MLAB
Market Cap
Forward P/E 0.0 18.7
Trailing P/E 55.4 82.8
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.4% 0.6%
Operating Margin 0.0% 0.0%
EPS 0.04 1.22
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, MLAB is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.